• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Ferndale launches aesthetic division


Ferndale, Mich. — Ferndale Laboratories has created a new aesthetic division, Biopelle, dedicated exclusively to aesthetic medicine, according to company president Dr. Michael Burns.

"We are proud to announce the launch of Biopelle," he says. "We firmly believe that we can bring special expertise and value to the rapidly growing area of aesthetic medicine."

The division has its own sales force headed by national sales director Elliott Milstein and its own marketing team led by product manager Richard Lawrence. Currently Biopelle markets two products: L.M.X.4 (lidocaine 4 percent) Topical Anesthetic Cream and OC Eight Matifying Gel. Biopelle plans to introduce two new products in the next six months, according to Mr. Lawrence.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.